Skip to main content

Zosano Pharma Corp

ZSANDelisted Jul 19, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001587221

Zosano Pharma Corp was delisted on Jul 19, 2022; its insiders filed their last Form 4 on Jun 7, 2022; 30 institutions reported holding it in 13F filings for Q1 2022, worth $2.89M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Zosano Pharma Corp changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ZSAN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3534−1
Shares11.1M13.7M+2.62M (+23.6%)
Value$13.7M$13.0M−$726.0K (−5.3%)

New holders (8)

Institutions that held Zosano Pharma Corp at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ZSAN in Q2 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC1,351,806$1.28M0.00%
State Street Corp418,916$398.0K0.00%
Millennium Management LLC68,904$65.0K0.00%
First Republic Investment Management, Inc.19,210$18.0K0.00%
Prime Capital Investment Advisors, LLC12,000$11.0K0.00%
Bank of America Corp49$00.00%
FMR LLC1$00.00%
Advisory Services Network, LLC122$00.00%

Sold out (9)

Institutions that held Zosano Pharma Corp at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ZSAN in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Winton Group Ltd64,558$80.0K
Bank of New York Mellon Corp41,720$52.0K
Two Sigma Securities, LLC32,523$40.0K
Tower Research Capital LLC (TRC)29,027$36.0K
Qube Research & Technologies Ltd27,514$34.0K
Squarepoint Ops LLC18,621$23.0K
Advisor Group Holdings, Inc.12,000$15.0K
Commonwealth Equity Services, LLC10,221$12.0K
Meridian Wealth Partners, LLC780$1.00K